Delivery Order SPE2DB20D6036-SPE2DB24FC8HS
Award Date 3/5/24
Potential Completion Date 3/6/24
Potential Value $7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order worth $1,741.62 by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, with a completion date of February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen Drug Corp and DLA, which serves as the primary contract vehicle for...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,900.16 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract with a potential value of $1,741.62 by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,641.94 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. The delivery order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,741.62 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $5,799.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. The contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, that serves as the primary...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a Firm Fixed Price Delivery Order by the Defense Logistics Agency (DLA) to provide the pharmaceutical product OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The award has a potential value of $1,161.08 and a performance period through February 21, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order worth $21,480.91 by the Defense Logistics Agency (DLA) for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency (DLA) has awarded a $5,431.64 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for delivering...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,483.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The delivery order is set to be completed by February 22, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver a comprehensive range of pharmaceutical products and...
- SPE2DB20D6036Indefinite Delivery Contract
- SPE2DB20D6036-SPE2DB24FC8HSDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $6,966.48 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.
Generated 6/4/24, 9:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 3/5/24 |